IL127295A - Liquisolid systems and methods of preparing same - Google Patents

Liquisolid systems and methods of preparing same

Info

Publication number
IL127295A
IL127295A IL12729596A IL12729597A IL127295A IL 127295 A IL127295 A IL 127295A IL 12729596 A IL12729596 A IL 12729596A IL 12729597 A IL12729597 A IL 12729597A IL 127295 A IL127295 A IL 127295A
Authority
IL
Israel
Prior art keywords
liquid
powder
carrier
liquisolid
coating
Prior art date
Application number
IL12729596A
Other languages
English (en)
Other versions
IL127295A0 (en
Original Assignee
Spireas Spiridon
Bolton Sanford M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24641555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127295(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Spireas Spiridon, Bolton Sanford M filed Critical Spireas Spiridon
Publication of IL127295A0 publication Critical patent/IL127295A0/xx
Publication of IL127295A publication Critical patent/IL127295A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
IL12729596A 1996-06-10 1997-06-09 Liquisolid systems and methods of preparing same IL127295A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,514 US5800834A (en) 1996-06-10 1996-06-10 Liquisolid systems and methods of preparing same
PCT/US1997/010093 WO1997047290A1 (fr) 1996-06-10 1997-06-09 Systemes liquisolides et leurs procedes de production

Publications (2)

Publication Number Publication Date
IL127295A0 IL127295A0 (en) 1999-09-22
IL127295A true IL127295A (en) 2002-05-23

Family

ID=24641555

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12729596A IL127295A (en) 1996-06-10 1997-06-09 Liquisolid systems and methods of preparing same

Country Status (12)

Country Link
US (2) US5800834A (fr)
EP (1) EP0946154B1 (fr)
JP (1) JP2000512295A (fr)
CN (1) CN1224379C (fr)
AT (1) ATE486584T1 (fr)
BR (1) BR9709778A (fr)
CA (1) CA2257890C (fr)
DE (1) DE69740040D1 (fr)
ES (1) ES2355871T3 (fr)
IL (1) IL127295A (fr)
RU (1) RU2209623C2 (fr)
WO (1) WO1997047290A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159419C (fr) * 1994-10-17 2006-07-04 Pieter De Haan Composition pharmaceutique solide renfermant un excipient pouvant fixer l'eau
JP4815053B2 (ja) 1998-08-13 2011-11-16 シーマ・ラブス、インコーポレイテッド 経口投与の固形投与形態物としてのマイクロエマルション
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
HK1040921B (en) * 1998-12-23 2005-12-30 Alza Corporation Dosage forms comprising porous particles
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7029700B2 (en) * 2000-01-14 2006-04-18 Brown University Research Foundation Micronized freeze-dried particles
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US7056951B2 (en) 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6692771B2 (en) 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
WO2002083102A1 (fr) * 2001-02-23 2002-10-24 Cima Labs Inc. Emulsions en formes posologiques solides pour l'administration orale
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) * 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
KR20120066688A (ko) * 2003-02-24 2012-06-22 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
AU2004277419B2 (en) * 2003-09-30 2007-10-11 Brown University Research Foundation Nanoparticulate therapeutic biologically active agents
EP1755559A1 (fr) * 2004-03-08 2007-02-28 Spiridon Spireas Compositions solides biodisponibles de metaxalone
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
WO2006023286A2 (fr) * 2004-08-19 2006-03-02 Alza Corporation Formes posologiques renfermant une formulation d'agent actif nanoparticulaire a liberation retardee et procedes
FR2894822B1 (fr) * 2005-12-20 2011-11-18 Pf Medicament Composition pharmaceutique contenant des acides gras omega-3
US7569612B1 (en) 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
WO2012027222A1 (fr) * 2010-08-24 2012-03-01 Rutgers, The State University Of New Jersey Formulation et fabrication de produits pharmaceutiques par imprégnation sur supports poreux
CN102949363A (zh) * 2012-11-28 2013-03-06 山东省中医药研究院 熊果酸液固压缩片
WO2014120922A1 (fr) 2013-02-01 2014-08-07 W. R. Grace & Co.-Conn. Gel de silice poreux comme support pour des technologies liquides
GB201812022D0 (en) * 2018-07-24 2018-09-05 Univ Of Sussex Pharmaceutical methods and compositions
EP4076501A4 (fr) 2019-12-16 2024-05-08 Rutgers, the State University of New Jersey Procédés continus de fabrication de supports poreux imprégnés et de fabrication de supports poreux imprégnés contenant des produits pharmaceutiques
US10744137B1 (en) * 2020-01-06 2020-08-18 King Abdulaziz University Liquisolid tablet containing combined dose of tadalafil and dapoxetine
CN111067875B (zh) * 2020-01-16 2021-11-30 兰州大学 一种阿苯达唑液固压缩片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368112A (en) * 1971-09-08 1974-09-25 Geistlich Soehne Ag Chemical compositions for the treatment of hyperlipemia
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
EP0546593B1 (fr) * 1991-10-30 1997-09-03 Glaxo Group Limited Compositions multicouches contenant d'antagonistes de l'histamine ou de la sérotonine

Also Published As

Publication number Publication date
BR9709778A (pt) 2000-01-11
ATE486584T1 (de) 2010-11-15
CA2257890C (fr) 2003-10-28
DE69740040D1 (de) 2010-12-16
JP2000512295A (ja) 2000-09-19
EP0946154B1 (fr) 2010-11-03
RU2209623C2 (ru) 2003-08-10
IL127295A0 (en) 1999-09-22
AU709566B2 (en) 1999-09-02
AU3387097A (en) 1998-01-07
EP0946154A1 (fr) 1999-10-06
EP0946154A4 (fr) 2007-02-07
US5968550A (en) 1999-10-19
WO1997047290A1 (fr) 1997-12-18
CN1221337A (zh) 1999-06-30
ES2355871T3 (es) 2011-03-31
CN1224379C (zh) 2005-10-26
HK1022844A1 (en) 2000-08-25
US5800834A (en) 1998-09-01
CA2257890A1 (fr) 1997-12-18

Similar Documents

Publication Publication Date Title
US5800834A (en) Liquisolid systems and methods of preparing same
US6423339B1 (en) Liquisolid systems and methods of preparing same
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
EP3102186B1 (fr) Compositions de donépézil et procédé de traitement de la maladie d'alzheimer
FI96095B (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
US9387191B2 (en) Ferric citrate dosage forms
KR930008956B1 (ko) 서방형 이부프로펜 제제의 제조방법
DK2217241T3 (en) WATER GRANULATION USING A WATER COMPLEX GENERATOR
Priya et al. Liquisolid technique an approach for enhancement of solubility
JP4532903B2 (ja) 微粒子組成物
AU709566C (en) Liquisolid systems and methods of preparing same
WO2010046418A1 (fr) Composition pharmaceutique contenant du lévétiracétam
Chowdary et al. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with β-cyclodextrin
Sharma et al. FORMULATION, OPTIMIZATION AND EVALUATION OF EXTENDED RELEASE TABLET OF CYANOCOBALAMIN BY USING POLYMER MATRIX SYSTEM
KR100490094B1 (ko) 액상/고상시스템및그제조방법
HK1022844B (en) Liquisolid systems and methods of preparing same
EP0443027B1 (fr) Medicament
MXPA98010456A (en) Liquisolid systems and methods to prepare losmis
US6077535A (en) Direct compression carbonyl iron tablet
Ogaji et al. Binding effects of two brands of pregelatinised starch on acetaminophen tablets in a wet granulation process
Jones et al. Matrix forming capabilities of three calcium diluents
Patel et al. Liquisolid technology: a novel approach to enhance solubility of poorly water soluble drugs
Stamm et al. Some aspects of the formulation of hard gelatin capsules
Jain et al. Asian Journal of Pharmaceutical Education and Research

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired